KCTD9P5

Across TCGA pan-cancer cohorts, KCTD9P5 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of KCTD9P5’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where KCTD9P5 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types KCTD9P5 is over-expressed in tumor.

LUSC and KIRP are the cancer types where KCTD9P5 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in KCTD9P5 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	Male	All	+0.017	.021	2	view →
KIRP	Female	All	+0.037	.007	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

KCTD9P5–LUSC

Open the LUSC breakdown →